phosphodiesterase/гојазност

Веза се чува у привремену меморију

Изаберите тип сортирања

Страна 1 од 325 резултати

A stop-codon of the phosphodiesterase 11A gene is associated with elevated blood pressure and measures of obesity.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE To identify stop-codon variants associated with blood pressure (BP). METHODS Illumina exome chip was genotyped in 5453 individuals of the population-based Malmö Diet and Cancer Study. We compared BP levels between carriers and noncarriers of all stop-codon variants found in at least 10

Phosphodiesterase 4 inhibition as a potential new therapeutic target in obese women with polycystic ovary syndrome.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Phosphodiesterase (PDE) enzymes, including members of PDE4, have been investigated in the regulation of endocrine and reproductive functions of ovaries. In addition, selective inhibition of PDE4 enzyme has recently been implicated in the regulation of metabolism with positive effects on

Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

People in modern, affluent societies are living longer but also becoming increasingly overweight. With increased life expectancy comes increased risk of developing age-related cognitive decline and neurodegenerative diseases, such that an increasing proportion of life may be lived with cognitive

Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE To prove that phosphodiesterase type-4 inhibitors could potentially treat obesity-associated overactive bladder through modulation of the systemic inflammatory response. METHODS In this 12-week study, 90 female Sprague-Dawley rats were divided into three groups: (1) vehicle-treated normal

Studies of phosphodiesterase effects on adipose tissue metabolism in obese subjects by the microdialysis technique.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

The effect of non-selective (theophylline) inhibition of cyclic AMP breakdown on norepinephrine stimulated lipolysis rate was investigated in subcutaneous adipose tissue of obese subjects. In addition, changes in interstitial glucose and lactate concentration were assessed by means of the

Effect of the rs997509 polymorphism on the association between ectonucleotide pyrophosphatase phosphodiesterase 1 and metabolic syndrome and impaired glucose tolerance in childhood obesity.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Variants on the nucleotide pyrophosphatase/phosphodiesterase-1 (ENPP-1) gene have been associated with obesity and insulin resistance. Because insulin resistance is a pivotal factor in the development of metabolic syndrome (MS) and impaired glucose tolerance (IGT), we aimed to test the

Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Cardiovascular diseases represent a significant cause of morbidity and mortality in diabetes. Of the many animal models used in the study of non-insulin-dependent (type 2) diabetes, the JCR:LA-cp rat is unique in that it develops insulin resistance in the presence of obesity and manifests both

Phosphodiesterase-3B-cAMP pathway of leptin signalling in the hypothalamus is impaired during the development of diet-induced obesity in FVB/N mice.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

The phosphodiesterase-3B (PDE3B)-cAMP pathway plays an important role in transducing the action of leptin in the hypothalamus. Obesity is usually associated with hyperleptinaemia and resistance to anorectic and body weight-reducing effects of leptin. To determine whether the hypothalamic PDE3B-cAMP

Decreased permeability surface area for glucose in obese women with postprandial hyperglycemia: no effect of phosphodiesterase-5 (PDE-5) inhibition.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Insulin-mediated microvascular recruitment is recognized as a potential mechanism contributing to insulin resistance. In this study, we compared a marker of microvascular function, the permeability surface area for glucose (PS(glu)), and forearm glucose uptake after an OGTT in obese women with

Effect of phosphodiesterase inhibition on insulin resistance in obese individuals.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Obesity is associated with cardiometabolic disease, including insulin resistance (IR) and diabetes. Cyclic guanosine monophosphate (cGMP) signaling affects energy balance, IR, and glucose metabolism in experimental models. We sought to examine effects of phosphodiesterase-5 inhibition

Alterations in cyclic nucleotide phosphodiesterase activities in omental and subcutaneous adipose tissues in human obesity.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE To elucidate the activity and expression of cyclic nucleotide phosphodiesterase (PDE) families in omental (OM) and subcutaneous (SC) adipose tissue and adipocytes, and to study alterations in their activity in human obesity. METHODS Cross-sectional, translational research study. METHODS In

Expression of ectonucleotide pyrophosphate phosphodiesterase and peroxisome proliferator activated receptor gamma in morbidly obese patients.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Recently, two genes, peroxisome proliferator activated receptor gamma (PPARgamma) and ectonucleotide pyrophosphate phosphodiesterase (ENPP1), have been localized and associated with diabetes and obesity. This report hypothesizes that there is a correlation between the genetic expression

Insulin-sensitive phosphodiesterase and insulin receptor binding in fat cells from spontaneously obese rats.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

The effects of insulin on insulin-sensitive phosphodiesterase were investigated in fat cells from rats aged 4, 8 and 16 weeks. The enzyme activities in rats aged 4 and 8 weeks higher at 0.1-30 nmol/l insulin concentrations than in rats aged 16 weeks, and half-maximum stimulations were obtained at

Phosphodiesterase 5 inhibitor ameliorates renal resistance to atrial natriuretic peptide associated with obesity and hyperleptinemia.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Abnormal neurohormonal regulation of renal sodium handling plays an important role in obesity-associated hypertension. We investigated the effect of experimental obesity on renal response to atrial natriuretic peptide (ANP). METHODS The effect of ANP was studied in three groups of rats:

Impact of phosphodiesterase 8B gene rs4704397 variation on thyroid homeostasis in childhood obesity.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Several studies demonstrated that obese children have higher TSH than normal-weight children. The polymorphism rs4704397 in the phosphodiesterase 8B (PDE8B) gene showed an association with TSH. OBJECTIVE i) To assess the effect of PDE8B on TSH in obese children; ii) to dissect the role of

Претходна
1
2
3
4
5
6
...
21
22
Следећи

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима